Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product

Stock News

May 26

Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of "Antelope Horn Powder Capsules [Tongrentang]" in the Hong Kong Special Administrative Region of the People's Republic of China.

Following the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1106851842"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1106851842\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1106851842?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 16:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106851842","market":"fut","top_or_hot":-1,"title":"Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product","media":"Stock News","content":"<p>Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of \"Antelope Horn Powder Capsules [Tongrentang]\" in the Hong Kong Special Administrative Region of the People's Republic of China.</p>\n<p>Following the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-26 16:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of \"Antelope Horn Powder Capsules [Tongrentang]\" in the Hong Kong Special Administrative Region of the People's Republic of China.</p>\n<p>Following the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"","article_id":"1106851842","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106851842","pubTimestamp":1779783198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600085":"同仁堂","BK0028":"国家队","BK0097":"医药电商","BK0239":"医药制造","03613":"同仁堂国药","BK0113":"养老产业","BK0086":"举牌","BK0183":"MSCI概念","BK0188":"融资融券","BK1606":"中医药概念","LU1688375341.USD":"贝莱德中国灵活股票基金","BK1191":"制药","BK0012":"证金概念","BK0196":"行业龙头"},"translate_title":"同仁堂子公司中药产品获香港注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600085":1,"03613":1},"content_text":"Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of \"Antelope Horn Powder Capsules [Tongrentang]\" in the Hong Kong Special Administrative Region of the People's Republic of China.\nFollowing the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}